Research Articles | Page 100 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Clinical results with the DNA hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in patients with myelodysplastic syndromes: an update Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Lenalidomide for del(5q) and Non-del(5q) Myelodysplastic Syndromes Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Immunomodulatory treatment of myelodysplastic syndromes: antithymocyte globulin, cyclosporine, and alemtuzumab Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Overview of myelodysplastic syndromes Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Detection of paroxysmal nocturnal hemoglobinuria (PNH) in bone marrow aspirates Jan 2019 Semin Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Anemia as the Main Manifestation of Myelodysplastic Syndromes Oct 2015 Semin Hematol myelodysplastic syndromes (MDS)
Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond Sep 2017 Semin Hematol myelodysplastic syndromes (MDS)
Optimizing the use of hypomethylating agents in myelodysplastic syndromes: Selecting the candidate, predicting the response, and enhancing the activity Sep 2017 Semin Hematol myelodysplastic syndromes (MDS)
Alternative donor transplants for severe aplastic anemia: current experience Jan 2016 Semin Hematol aplastic anemia
Increasing the effectiveness of hematopoiesis in myelodysplastic syndromes: erythropoiesis-stimulating agents and transforming growth factor-β superfamily inhibitors Sep 2017 Semin Hematol myelodysplastic syndromes (MDS)
Share with addtoany.com.